BioSpace News Archive

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced financial and operating results for the first quarter ended March 31, 2021 and provided a business update.

New report finds use of data analytics technology in the OR lead to higher retention compared to ORs that did not use the technology

Eli Lilly and Company (NYSE: LLY) will participate in the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 . Anat Ashkenazi, senior vice president and chief financial officer, will participate in a virtual fireside chat at 10:00 a.m., Eastern Time .

Circuit Clinical, an integrated research platform dedicated to bringing clinical research as a care option to everyone, announced they have been recognized by Inc. Magazine’s annual list of the Best Workplaces for 2021.

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully-human polyclonal antibodies, today announced that Eddie J. Sullivan, PhD, co-founder, president and CEO, will participate in a fireside chat at the RBC Capital Markets 2021 Global Healthcare Conference on Thursday, May 20, 2021 at 11:30 a.m. ET.

Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the appointment of Matthias Weber, former President of Leica Biosystems, to its Board of Directors.

Proscia®, a leading provider of digital and computational pathology solutions, today announces Future Ready Pathology, an industry event for helping diagnostic laboratories rapidly modernize in the post-pandemic era and beyond.

Amsterdam, The Netherlands, 13 May 2021 – Kiadis Pharma N.V., a clinical-stage biopharmaceutical company, announces that its Annual General Meeting of shareholders will be held at 15:00 CEST on 28 June 2021.

UL, the global safety science leader, has rolled out a new software tool providing employers with streamlined digital tracking and recording capabilities for their employees’ COVID-19 vaccinations as return-to-work programs gear up across the United States.

Interline Therapeutics, a Foresite Labs incubated company focused on systematically elucidating protein communities to define molecular mechanisms of disease, announced today that the company has raised $92 million.